Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PREdiCtIon of Weanability, Survival and Functional outcomEs After ECLS

NCT05444764 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT05444764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05444764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PREdiCtIon of Weanability, Survival and Functional outcomEs After ECLS
Lead sponsor
UMC Utrecht
Phase
Observational
Overall status
Unknown status
Start date
September 16, 2021
Completion date
March 1, 2024
Enrollment
800 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

extracorporeal membrane oxygenation, extracorporeal membrane oxygenation complication